Löwe Bernd, Kroenke Kurt, Herzog Wolfgang, Gräfe Kerstin
Department of General Internal and Psychosomatic Medicine, University of Heidelberg, Medical Hospital, Germany.
J Affect Disord. 2004 Jul;81(1):61-6. doi: 10.1016/S0165-0327(03)00198-8.
The nine-item depression module from the Patient Health Questionnaire (PHQ-9) is well validated and widely used as a brief diagnostic and severity measure, but its validity as an outcome measure for depression has not yet been established. Therefore, we investigated the sensitivity to change of the PHQ-9 in three groups of patients whose depression status either improved, remained unchanged, or deteriorated over time.
From three cohorts of medical outpatients, with an equal distribution of major depressive disorder, other depressive disorders, or no depressive disorder, 167 patients (82.7%) were followed up after a mean of 12.3 +/- 3.0 months. The PHQ-9 and the Structured Clinical Interview for DSM-IV (SCID) were completed at both baseline and follow-up. Depression diagnoses from the SCID were used as the criterion standard to divide patients into subgroups with (a) improved depression status, (b) unchanged depression status, and (c) deteriorated depression status.
Effect sizes (ES) of PHQ-9 change scores were ES = -1.33 for the improved depression status subgroup (n = 52), ES = -0.21 for the unchanged status subgroup (n = 91), and ES = 0.47 for the deteriorated status subgroup (n = 24). PHQ-9 change scores differed significantly between the three depression outcome groups.
The PHQ-9 and the SCID were completed in person at baseline, whereas they were completed in a telephone interview at follow-up.
This study demonstrates the ability of the PHQ-9 to detect depression outcome and changes over time. Data from treatment trials will help further establish the sensitivity to change of the PHQ-9 in comparison to other depression severity measures.
患者健康问卷(PHQ - 9)中的九项抑郁模块经过充分验证,被广泛用作简短的诊断和严重程度测量工具,但尚未确立其作为抑郁结局测量指标的有效性。因此,我们调查了PHQ - 9在三组患者中的变化敏感性,这三组患者的抑郁状态随时间推移分别有所改善、保持不变或恶化。
从三个队列的门诊患者中选取,其中重度抑郁症、其他抑郁症或无抑郁症患者分布均衡,平均随访12.3±3.0个月后,167名患者(82.7%)被纳入研究。在基线和随访时均完成了PHQ - 9和《精神疾病诊断与统计手册》第四版(DSM - IV)的结构化临床访谈(SCID)。以SCID的抑郁诊断作为标准,将患者分为以下亚组:(a)抑郁状态改善;(b)抑郁状态不变;(c)抑郁状态恶化。
抑郁状态改善亚组(n = 52)的PHQ - 9变化评分效应量(ES)为ES = -1.33,状态不变亚组(n = 91)为ES = -0.21,状态恶化亚组(n = 24)为ES = 0.47。三个抑郁结局组之间的PHQ - 9变化评分差异显著。
PHQ - 9和SCID在基线时是面对面完成的,而在随访时是通过电话访谈完成的。
本研究证明了PHQ - 9检测抑郁结局及随时间变化的能力。与其他抑郁严重程度测量指标相比,来自治疗试验的数据将有助于进一步确定PHQ - 9的变化敏感性。